Cargando…
Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnos...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075471/ https://www.ncbi.nlm.nih.gov/pubmed/29518421 http://dx.doi.org/10.1016/j.jaci.2018.01.043 |
_version_ | 1783344591473213440 |
---|---|
author | Bahri, Rajia Custovic, Adnan Korosec, Peter Tsoumani, Marina Barron, Martin Wu, Jiakai Sayers, Rebekah Weimann, Alf Ruiz-Garcia, Monica Patel, Nandinee Robb, Abigail Shamji, Mohamed H. Fontanella, Sara Silar, Mira Mills, E.N.Clare Simpson, Angela Turner, Paul J. Bulfone-Paus, Silvia |
author_facet | Bahri, Rajia Custovic, Adnan Korosec, Peter Tsoumani, Marina Barron, Martin Wu, Jiakai Sayers, Rebekah Weimann, Alf Ruiz-Garcia, Monica Patel, Nandinee Robb, Abigail Shamji, Mohamed H. Fontanella, Sara Silar, Mira Mills, E.N.Clare Simpson, Angela Turner, Paul J. Bulfone-Paus, Silvia |
author_sort | Bahri, Rajia |
collection | PubMed |
description | BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. OBJECTIVE: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). METHODS: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients' sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. RESULTS: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D(2) and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. CONCLUSION: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions. |
format | Online Article Text |
id | pubmed-6075471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mosby |
record_format | MEDLINE/PubMed |
spelling | pubmed-60754712018-08-09 Mast cell activation test in the diagnosis of allergic disease and anaphylaxis Bahri, Rajia Custovic, Adnan Korosec, Peter Tsoumani, Marina Barron, Martin Wu, Jiakai Sayers, Rebekah Weimann, Alf Ruiz-Garcia, Monica Patel, Nandinee Robb, Abigail Shamji, Mohamed H. Fontanella, Sara Silar, Mira Mills, E.N.Clare Simpson, Angela Turner, Paul J. Bulfone-Paus, Silvia J Allergy Clin Immunol Article BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. OBJECTIVE: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). METHODS: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients' sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. RESULTS: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D(2) and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. CONCLUSION: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions. Mosby 2018-08 /pmc/articles/PMC6075471/ /pubmed/29518421 http://dx.doi.org/10.1016/j.jaci.2018.01.043 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bahri, Rajia Custovic, Adnan Korosec, Peter Tsoumani, Marina Barron, Martin Wu, Jiakai Sayers, Rebekah Weimann, Alf Ruiz-Garcia, Monica Patel, Nandinee Robb, Abigail Shamji, Mohamed H. Fontanella, Sara Silar, Mira Mills, E.N.Clare Simpson, Angela Turner, Paul J. Bulfone-Paus, Silvia Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title | Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title_full | Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title_fullStr | Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title_full_unstemmed | Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title_short | Mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
title_sort | mast cell activation test in the diagnosis of allergic disease and anaphylaxis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075471/ https://www.ncbi.nlm.nih.gov/pubmed/29518421 http://dx.doi.org/10.1016/j.jaci.2018.01.043 |
work_keys_str_mv | AT bahrirajia mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT custovicadnan mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT korosecpeter mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT tsoumanimarina mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT barronmartin mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT wujiakai mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT sayersrebekah mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT weimannalf mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT ruizgarciamonica mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT patelnandinee mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT robbabigail mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT shamjimohamedh mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT fontanellasara mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT silarmira mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT millsenclare mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT simpsonangela mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT turnerpaulj mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis AT bulfonepaussilvia mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis |